Health startup Medivo has raised $15 million to expand its health monitoring platform that connects doctors, consumers, and clinical labs. The company’s vision is to save and improve lives through faster and easier access to quality health care.

Its applications are designed to improve the level of understanding and communication between patients and providers. Patients get free, secure access to symptom-tracking tools and lab results along with simple explanations of those results. The system also helps patients understand connections between symptoms and factors like diet and medication and automatically reports that information back to the doctor.

Medivo organizes a patients’ lab results for providers so they can identify who needs office visits and prioritizes visits by who needs care the most. The condition management services analyzes patient data to see who needs what lab tests and which patients require urgent follow-up care.

The platform includes modules for physicians and patients with diabetes, dyslipidemia, hepatitis C, gout, low testosterone, irritable bowel disease, hereditary angioedema, and chronic myelogenous leukemia. This financing will support expanding the network of labs and modules to include obesity, rheumatoid arthritis, hepatitis B, HIV, colon cancer, breast cancer, prostate cancer, myelofibrosis, multiple myeloma, growth hormone deficiency, osteoporosis, hypothyroidism, and multiple sclerosis.

See on venturebeat.com